A recent report published by Infinium Global Research on albumin market provides in-depth analysis of segments and sub-segments in the global as well as regional albumin market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional albumin market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global albumin market. According to the report, the global albumin market is projected to grow at a CAGR of 6.8% over the forecast period of 2018-2024.
Albumin is a water-soluble protein
founded in blood plasma. It acts as a transponder for various substances such
as hormones, vitamins, and enzymes. It plays a predominant role in regulating
blood function. Albumin has a different application like the stabilizer,
antibacterial, antioxidant, the universal carrier in rheumatoid arthritis and
plays a role in the delivery of anticancer drugs. Serum albumin is the most
abundant blood plasma protein. Human serum albumin and bovine serum albumin are
different type’s serum albumin that is obtained from human plasma and bovine
Growing occurrence of rare diseases,
shocks, trauma, liver conditions, burns, and other injury or surgery is the key
factor that promotes the growth of the albumin market. Albumin is used to
replace blood volume loss resulting from trauma such as severe burns or an
injury that causes blood loss. Moreover, the rising consumption of albumin in
various application such as drug discovery, drug formulation, and vaccines
contributes to the growth of this market. Albumin has been used to prepare
microcapsules for drug delivery system.
Apart from this, expanding awareness
about the benefits of albumin, the rise in the non-therapeutic application of
albumin and high demand for albumin in research and development activities are
other key factors drives the growth of the market. However, the adverse effects
associated with human serum albumin (HSA) administration and strict regulations
criteria are hampering the growth of albumin market. The shift towards
serum-free products is having a negative impact on the growth of the market.
Furthermore, technological advancement in drug delivery and drug formulations
creates significant opportunities for the albumin market.
North America and
Europe region is expected to be the attractive market for albumin due to rapid
development in the use of albumin for non-therapeutical applications. A large
number of pharmaceutical companies and research institutes are more invested in
life science is anticipated to escalate the growth of the market. Asia-Pacific is the fastest growing region in the albumin market owing to the
growing awareness about albumin product. Countries such as China, India, Korea,
and Japan are significantly focusing on medical research. The use of albumin
for research purpose has a positive impact on the growth of albumin market in
the Middle East and Africa region.
The report on global albumin market covers segments such as source, type, application, and end user. On the basis of source, the sub-markets include animal sources and plant sources. On the basis of type, the sub-markets include human serum albumin bovine serum albumin and recombinant albumin. On the basis of application, the sub-markets include drug delivery, therapeutic, culture media, and vaccine ingredient. On the basis of the end user, the sub-markets include pharmaceutical & biotechnology, research institutes, and others.
The report provides profiles of the companies in the market such as Baxalta Incorporated, Amgen, Biotest AG, Baxter International Inc., China Biologic Products, Inc., Celgene, Grifols SA, Mitsubishi Tanabe Pharma, CSL Behring LLC, Octapharma AG, Novozymes A/S, and Sigma-Aldrich Co.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of albumin market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.